公开(公告)号：US20210059968A1

公开(公告)日：2021-03-04

申请号：US16854079

申请日：2020-04-21

申请人： AbbVie Inc.

发明人： Alexandru DEAC ,  Ye HUANG ,  John M. LIPARI ,  Alexander RUGGLES ,  Thin Yu TUN

IPC分类号： A61K31/198 ,  A61K47/32 ,  A61K47/10 ,  A61K47/38 ,  A61K9/10 ,  A61K9/00 ,  A61K31/195

摘要： The present disclosure provides (a) a pharmaceutical composition comprising a levodopa active agent and a carbidopa active agent and (b) methods of treating Parkinson's disease and associated conditions comprising administering the pharmaceutical composition to a subject with Parkinson's disease.

公开(公告)号：US20230129413A1

公开(公告)日：2023-04-27

申请号：US17817191

申请日：2022-08-03

申请人： AbbVie Inc.

发明人： Alexandru DEAC ,  Ye HUANG ,  John M. LIPARI ,  Alexander RUGGLES ,  Thin Yu TUN

IPC分类号： A61K31/198 ,  A61K47/32 ,  A61K47/10 ,  A61K47/38 ,  A61K9/10 ,  A61K9/00 ,  A61K31/195

摘要： The present disclosure provides (a) a pharmaceutical composition comprising a levodopa active agent and a carbidopa active agent and (b) methods of treating Parkinson's disease and associated conditions comprising administering the pharmaceutical composition to a subject with Parkinson's disease.

公开(公告)号：US20180021280A1

公开(公告)日：2018-01-25

申请号：US15655078

申请日：2017-07-20

申请人： AbbVie Inc.

发明人： Alexandru DEAC ,  Ye HUANG ,  John M. LIPARI ,  Alexander RUGGLES ,  Thin Yu TUN

IPC分类号： A61K31/198 ,  A61K9/00 ,  A61K47/38 ,  A61K9/10 ,  A61K47/32 ,  A61K47/10

CPC分类号： A61K31/198 ,  A61K9/00 ,  A61K9/0053 ,  A61K9/10 ,  A61K31/195 ,  A61K47/10 ,  A61K47/32 ,  A61K47/38 ,  A61K2300/00

摘要： The present disclosure provides (a) a pharmaceutical composition comprising a levodopa active agent and a carbidopa active agent and (b) methods of treating Parkinson's disease and associated conditions comprising administering the pharmaceutical composition to a subject with Parkinson's disease.